Nanovaccine Confers Dual Protection Against Influenza a Virus and Porcine Circovirus Type 2 [Retraction]

Abstract

Ding P, Jin Q, Chen X, et al. Int J Nanomedicine. 2019;14:7533-7548. At the author’s request, we, the Editor and Publisher of the journal International Journal of Nanomedicine have retracted the following article. During a recent review of the article, the authors identified an error in the use of the transmission electron microscopy (TEM) images for Figure 2A, which could potentially confuse readers. After discussing this issue with the editorial team and providing the original data, the authors agreed that the potential confusion could not be adequately addressed through simple correction. Although the results of TEM were independent of the in vivo and in vitro experiments and did not affect the effectiveness of the nanovaccines in the study, they could have compromised the accuracy and reliability of the findings. The authors apologize for the errors in the article and appreciate the readership’s understanding in this matter. However, the authors remain confident in the results and conclusions of this study and with the original material well preserved, hope to submit a revised version of the article for republication following reevaluation. The journal has acknowledged this. In the meantime, in the interest of upholding research integrity and ensuring the trustworthiness of the scientific record, the authors believe that it is necessary to retract the article. We, the Editor and Publisher, understand and agreed with this decision. We have been informed in our decision-making by our editorial policies and COPE guidelines. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Keywords

• influenza a virus
• porcine circovirus type 2
• m2e
• nanovaccine
• virus-like particles
• bivalent vaccine